These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36348154)

  • 21. Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil.
    Fernandes EG; Sartori AMC; de Soárez PC; Amaku M; de Azevedo Neto RS; Novaes HMD
    Vaccine; 2020 Jan; 38(1):46-53. PubMed ID: 31648911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?
    Van Bellinghen LA; Dimitroff A; Haberl M; Li X; Manton A; Moeremans K; Demarteau N
    Hum Vaccin Immunother; 2018; 14(9):2263-2273. PubMed ID: 29771574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-benefit analysis of hospital based postpartum vaccination with combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap).
    Ding Y; Yeh SH; Mink CA; Zangwill KM; Allred NJ; Hay JW
    Vaccine; 2013 May; 31(22):2558-64. PubMed ID: 23583811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of adult pertussis vaccination in Germany.
    Lee GM; Riffelmann M; Wirsing von Konig CH
    Vaccine; 2008 Jul; 26(29-30):3673-9. PubMed ID: 18538901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic Evaluation and Budget Impact Analysis of Vaccination against
    Kotirum S; Muangchana C; Techathawat S; Dilokthornsakul P; Wu DB; Chaiyakunapruk N
    Front Public Health; 2017; 5():289. PubMed ID: 29209602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients.
    Sangmala P; Chaikledkaew U; Tanwandee T; Pongchareonsuk P
    Asian Pac J Cancer Prev; 2014; 15(20):8993-9004. PubMed ID: 25374242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of a pertussis vaccination programme for Japan considering intergenerational infection.
    Itatani T; Shimizu S; Iwasa M; Ohkusa Y; Hayakawa K
    Vaccine; 2013 Jun; 31(27):2891-7. PubMed ID: 23570987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand.
    Permsuwan U; Thongprasert S; Sirichanchuen B
    Value Health Reg Issues; 2020 May; 21():9-16. PubMed ID: 31634796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand.
    Leelahavarong P; Chaikledkaew U; Hongeng S; Kasemsup V; Lubell Y; Teerawattananon Y
    BMC Health Serv Res; 2010 Jul; 10():209. PubMed ID: 20633303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
    Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
    PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.
    Terranella A; Asay GR; Messonnier ML; Clark TA; Liang JL
    Pediatrics; 2013 Jun; 131(6):e1748-56. PubMed ID: 23713104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women.
    Wanlapakorn N; Maertens K; Chaithongwongwatthana S; Srimuan D; Suratannon N; Vongpunsawad S; Tran TMP; Hens N; Van Damme P; Locht C; Poovorawan Y; Leuridan E
    Vaccine; 2018 Mar; 36(11):1453-1459. PubMed ID: 29426663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling the cost-effectiveness of maternal acellular pertussis immunization (aP) in different socioeconomic settings: A dynamic transmission model of pertussis in three Brazilian states.
    Luz PM; Struchiner CJ; Kim SY; Minamisava R; Andrade ALS; Sanderson C; Russell LB; Toscano CM
    Vaccine; 2021 Jan; 39(1):125-136. PubMed ID: 33303180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-utility analysis of dasatinib and nilotinib in patients with chronic myeloid leukemia refractory to first-line treatment with imatinib in Thailand.
    Kulpeng W; Sompitak S; Jootar S; Chansung K; Teerawattananon Y
    Clin Ther; 2014 Apr; 36(4):534-43. PubMed ID: 24635968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis.
    Kandeil W; van den Ende C; Bunge EM; Jenkins VA; Ceregido MA; Guignard A
    Expert Rev Vaccines; 2020 Jul; 19(7):621-638. PubMed ID: 32772755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.
    Sirivichayakul C; Chanthavanich P; Limkittikul K; Siegrist CA; Wijagkanalan W; Chinwangso P; Petre J; Hong Thai P; Chauhan M; Viviani S
    Hum Vaccin Immunother; 2017 Jan; 13(1):136-143. PubMed ID: 27686283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.
    Wang Y; Luangasanatip N; Pan-Ngum W; Isaranuwatchai W; Prawjaeng J; Saralamba S; Painter C; Briones JR; Teerawattananon Y
    Eur J Health Econ; 2023 Jul; 24(5):735-748. PubMed ID: 35951243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
    Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of maternal pertussis immunization: Implications of a dynamic transmission model for low- and middle-income countries.
    Kim SY; Min KD; Jung SM; Russell LB; Toscano C; Minamisava R; Andrade ALS; Sanderson C; Sinha A
    Vaccine; 2021 Jan; 39(1):147-157. PubMed ID: 33303182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand.
    Termrungruanglert W; Khemapech N; Vasuratna A; Havanond P; Deebukkham P; Kulkarni AS; Pavelyev A
    PLoS One; 2021; 16(2):e0245894. PubMed ID: 33571186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.